Coloplast Logo

Coloplast

ISIN: DK0060448595 | Ticker: COLO | LEI: 529900NN7SOJ5QG82X67
Sector: Health CareSub-Industry: Health Care Supplies
Country: Denmark

About Coloplast

Company Description

Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. These conditions are often associated with trauma and taboo. The more intimate the condition, the greater the requirement to come closer to customers, understand their world and develop solutions that are sensitive to their special needs. We call this intimate healthcare.

Closeness to all customers makes this possible. We listen to better understand needs and respond by finding new ways to do things better together. We lead the way by bringing the best ideas first and fast to market in the form of medical devices and service solutions.

Deeply private and personal medical conditions are our focus. Our passion to make a real difference to people’s lives is what drives and unites us. Our culture supports high ambitions and releases the full potential of our own people to achieve them.

Year founded

1957

Headcount

14,000

Headquarters

Holtedam 1, 3050 Humlebaek – Denmark

Financial statements

Download as Excel
Line item in (eur) 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023 01.10.2023
Assets N/A 14,926,000,000.00 15,249,000,000.00 15,458,000,000.00 15,841,000,000.00 16,188,000,000.00 35,170,000,000.00 35,185,000,000.00 34,956,000,000.00 35,221,000,000.00 35,302,000,000.00 35,087,000,000.00 48,159,000,000.00
Noncurrent Assets N/A 8,286,000,000.00 8,542,000,000.00 8,631,000,000.00 8,847,000,000.00 8,904,000,000.00 27,001,000,000.00 26,482,000,000.00 26,184,000,000.00 25,942,000,000.00 25,979,000,000.00 25,414,000,000.00 38,222,000,000.00
Property Plant And Equipment N/A 3,424,000,000.00 3,569,000,000.00 3,660,000,000.00 3,785,000,000.00 3,845,000,000.00 4,220,000,000.00 4,237,000,000.00 4,474,000,000.00 4,557,000,000.00 4,788,000,000.00 4,941,000,000.00 5,131,000,000.00
Other Noncurrent Receivables N/A 23,000,000.00 24,000,000.00 31,000,000.00 26,000,000.00 26,000,000.00 28,000,000.00 29,000,000.00 31,000,000.00 30,000,000.00 35,000,000.00 36,000,000.00 39,000,000.00
Deferred Tax Assets N/A 669,000,000.00 711,000,000.00 709,000,000.00 743,000,000.00 739,000,000.00 849,000,000.00 847,000,000.00 674,000,000.00 663,000,000.00 656,000,000.00 661,000,000.00 884,000,000.00
Noncurrent Investments Other Than Investments Accounted For Using Equity Method N/A 25,000,000.00 25,000,000.00 25,000,000.00 41,000,000.00 41,000,000.00 41,000,000.00 43,000,000.00 51,000,000.00 51,000,000.00 68,000,000.00 68,000,000.00 65,000,000.00
Current Assets N/A 6,640,000,000.00 6,707,000,000.00 6,827,000,000.00 6,994,000,000.00 7,284,000,000.00 8,169,000,000.00 8,703,000,000.00 8,772,000,000.00 9,279,000,000.00 9,323,000,000.00 9,673,000,000.00 9,937,000,000.00
Inventories N/A 2,231,000,000.00 2,289,000,000.00 2,378,000,000.00 2,428,000,000.00 2,497,000,000.00 2,870,000,000.00 3,022,000,000.00 3,187,000,000.00 3,397,000,000.00 3,512,000,000.00 3,557,000,000.00 3,522,000,000.00
Current Trade Receivables N/A 2,916,000,000.00 3,108,000,000.00 3,142,000,000.00 3,212,000,000.00 3,215,000,000.00 3,648,000,000.00 3,837,000,000.00 3,940,000,000.00 3,953,000,000.00 3,988,000,000.00 4,072,000,000.00 4,315,000,000.00
Current Prepayments N/A 172,000,000.00 180,000,000.00 165,000,000.00 172,000,000.00 181,000,000.00 241,000,000.00 214,000,000.00 293,000,000.00 399,000,000.00 395,000,000.00 368,000,000.00 384,000,000.00
Other Current Receivables N/A 384,000,000.00 194,000,000.00 205,000,000.00 226,000,000.00 240,000,000.00 321,000,000.00 414,000,000.00 383,000,000.00 318,000,000.00 394,000,000.00 341,000,000.00 273,000,000.00
Current Tax Assets Current N/A 245,000,000.00 261,000,000.00 262,000,000.00 282,000,000.00 287,000,000.00 352,000,000.00 362,000,000.00 336,000,000.00 331,000,000.00 390,000,000.00 480,000,000.00 532,000,000.00
Cash and cash equivalents 323,000,000.00 435,000,000.00 418,000,000.00 447,000,000.00 448,000,000.00 642,000,000.00 517,000,000.00 634,000,000.00 414,000,000.00 671,000,000.00 628,000,000.00 855,000,000.00 911,000,000.00
Current Investments N/A 257,000,000.00 257,000,000.00 228,000,000.00 226,000,000.00 222,000,000.00 220,000,000.00 220,000,000.00 219,000,000.00 210,000,000.00 16,000,000.00 0.00 0.00
Equity And Liabilities N/A 14,926,000,000.00 15,249,000,000.00 15,458,000,000.00 15,841,000,000.00 16,188,000,000.00 35,170,000,000.00 35,185,000,000.00 34,956,000,000.00 35,221,000,000.00 35,302,000,000.00 35,087,000,000.00 48,159,000,000.00
Equity 7,406,000,000.00 5,770,000,000.00 6,936,000,000.00 6,927,000,000.00 8,168,000,000.00 6,419,000,000.00 7,273,000,000.00 7,275,000,000.00 8,292,000,000.00 5,905,000,000.00 7,034,000,000.00 6,490,000,000.00 17,299,000,000.00
Issued Capital N/A 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 216,000,000.00 228,000,000.00
Retained Earnings N/A 5,876,000,000.00 6,080,000,000.00 7,111,000,000.00 5,406,000,000.00 6,668,000,000.00 6,182,000,000.00 7,429,000,000.00 5,386,000,000.00 6,451,000,000.00 6,572,000,000.00 7,877,000,000.00 14,632,000,000.00
Noncurrent Liabilities N/A 1,374,000,000.00 1,491,000,000.00 1,415,000,000.00 1,359,000,000.00 1,292,000,000.00 3,086,000,000.00 19,275,000,000.00 19,328,000,000.00 18,834,000,000.00 18,835,000,000.00 18,759,000,000.00 14,549,000,000.00
Noncurrent Provisions For Employee Benefits N/A 193,000,000.00 161,000,000.00 165,000,000.00 181,000,000.00 159,000,000.00 141,000,000.00 98,000,000.00 115,000,000.00 118,000,000.00 111,000,000.00 123,000,000.00 124,000,000.00
Other Longterm Provisions N/A 71,000,000.00 226,000,000.00 176,000,000.00 56,000,000.00 27,000,000.00 179,000,000.00 73,000,000.00 258,000,000.00 199,000,000.00 198,000,000.00 123,000,000.00 71,000,000.00
Noncurrent Accruals And Noncurrent Deferred Income Including Noncurrent Contract Liabilities N/A N/A N/A 10,000,000.00 2,000,000.00 3,000,000.00 20,000,000.00 20,000,000.00 7,000,000.00 7,000,000.00 8,000,000.00 8,000,000.00 6,000,000.00
Other Noncurrent Payables N/A N/A N/A N/A 0.00 0.00 0.00 0.00 16,000,000.00 16,000,000.00 3,000,000.00 3,000,000.00 4,000,000.00
Deferred Tax Liabilities N/A 628,000,000.00 638,000,000.00 631,000,000.00 671,000,000.00 673,000,000.00 2,263,000,000.00 2,208,000,000.00 2,077,000,000.00 1,469,000,000.00 1,473,000,000.00 1,439,000,000.00 2,122,000,000.00
Noncurrent Portion Of Noncurrent Bonds Issued N/A N/A N/A 0.00 0.00 0.00 0.00 16,367,000,000.00 16,359,000,000.00 16,360,000,000.00 16,387,000,000.00 16,385,000,000.00 11,558,000,000.00
Current Liabilities N/A 7,782,000,000.00 6,822,000,000.00 7,116,000,000.00 6,314,000,000.00 8,477,000,000.00 24,811,000,000.00 8,635,000,000.00 7,336,000,000.00 10,482,000,000.00 9,433,000,000.00 9,838,000,000.00 16,311,000,000.00
Current Provisions For Employee Benefits N/A 13,000,000.00 13,000,000.00 13,000,000.00 15,000,000.00 15,000,000.00 5,000,000.00 5,000,000.00 6,000,000.00 6,000,000.00 5,000,000.00 5,000,000.00 7,000,000.00
Other Shortterm Provisions N/A 153,000,000.00 159,000,000.00 157,000,000.00 150,000,000.00 145,000,000.00 676,000,000.00 650,000,000.00 347,000,000.00 260,000,000.00 236,000,000.00 206,000,000.00 186,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 563,000,000.00 572,000,000.00 531,000,000.00 1,036,000,000.00 597,000,000.00 755,000,000.00 826,000,000.00 1,242,000,000.00 964,000,000.00 1,136,000,000.00 1,070,000,000.00 1,294,000,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A N/A N/A 2,000,000.00 8,000,000.00 6,000,000.00 4,000,000.00 7,000,000.00 2,000,000.00 1,000,000.00 1,000,000.00 1,000,000.00 1,000,000.00
Other Current Payables N/A 2,225,000,000.00 1,661,000,000.00 1,869,000,000.00 1,840,000,000.00 2,451,000,000.00 2,043,000,000.00 2,287,000,000.00 2,544,000,000.00 2,711,000,000.00 2,095,000,000.00 1,991,000,000.00 3,249,000,000.00
Current Tax Liabilities Current N/A 627,000,000.00 743,000,000.00 696,000,000.00 928,000,000.00 657,000,000.00 727,000,000.00 1,141,000,000.00 1,342,000,000.00 1,372,000,000.00 1,354,000,000.00 1,513,000,000.00 4,229,000,000.00
Current Bonds Issued And Current Portion Of Noncurrent Bonds Issued N/A N/A N/A N/A N/A N/A N/A N/A 0.00 N/A N/A N/A 4,847,000,000.00
Line item in (eur) 01.10.2020/
01.01.2021
01.10.2020/
01.04.2021
01.10.2020/
01.07.2021
01.10.2020/
01.10.2021
01.01.2021/
01.04.2021
01.03.2021/
01.07.2021
01.10.2021/
01.01.2022
01.10.2021/
01.04.2022
01.10.2021/
01.07.2022
01.10.2021/
01.10.2022
01.01.2022/
01.04.2022
01.03.2022/
01.07.2022
01.04.2022/
01.07.2022
01.10.2022/
01.01.2023
01.10.2022/
01.04.2023
01.10.2022/
01.07.2023
01.10.2022/
01.10.2023
01.01.2023/
01.04.2023
01.04.2023/
01.07.2023
Revenue 4,738,000,000.00 9,491,000,000.00 14,326,000,000.00 19,426,000,000.00 4,753,000,000.00 4,835,000,000.00 5,169,000,000.00 10,671,000,000.00 16,520,000,000.00 22,579,000,000.00 5,502,000,000.00 5,849,000,000.00 5,849,000,000.00 6,105,000,000.00 12,166,000,000.00 18,274,000,000.00 24,500,000,000.00 6,061,000,000.00 6,108,000,000.00
Other Income 15,000,000.00 25,000,000.00 57,000,000.00 73,000,000.00 10,000,000.00 32,000,000.00 14,000,000.00 29,000,000.00 59,000,000.00 74,000,000.00 15,000,000.00 30,000,000.00 30,000,000.00 9,000,000.00 26,000,000.00 39,000,000.00 56,000,000.00 17,000,000.00 13,000,000.00
Profit Loss From Operating Activities 1,536,000,000.00 2,913,000,000.00 4,505,000,000.00 6,155,000,000.00 1,377,000,000.00 1,592,000,000.00 1,615,000,000.00 2,920,000,000.00 4,661,000,000.00 6,439,000,000.00 1,305,000,000.00 1,741,000,000.00 1,741,000,000.00 1,761,000,000.00 3,412,000,000.00 5,126,000,000.00 6,771,000,000.00 1,651,000,000.00 1,714,000,000.00
Finance Income 18,000,000.00 85,000,000.00 129,000,000.00 137,000,000.00 67,000,000.00 44,000,000.00 19,000,000.00 69,000,000.00 148,000,000.00 119,000,000.00 50,000,000.00 79,000,000.00 79,000,000.00 31,000,000.00 73,000,000.00 110,000,000.00 191,000,000.00 42,000,000.00 37,000,000.00
Finance Costs 59,000,000.00 28,000,000.00 45,000,000.00 59,000,000.00 -31,000,000.00 17,000,000.00 77,000,000.00 145,000,000.00 294,000,000.00 431,000,000.00 68,000,000.00 149,000,000.00 149,000,000.00 365,000,000.00 597,000,000.00 738,000,000.00 937,000,000.00 232,000,000.00 141,000,000.00
Profit Loss Before Tax 1,495,000,000.00 2,970,000,000.00 4,589,000,000.00 6,233,000,000.00 1,475,000,000.00 1,619,000,000.00 1,557,000,000.00 2,844,000,000.00 4,515,000,000.00 6,127,000,000.00 1,287,000,000.00 1,671,000,000.00 1,671,000,000.00 1,427,000,000.00 2,888,000,000.00 4,498,000,000.00 6,025,000,000.00 1,461,000,000.00 1,610,000,000.00
Income Tax Expense Continuing Operations 359,000,000.00 704,000,000.00 1,069,000,000.00 1,408,000,000.00 345,000,000.00 365,000,000.00 350,000,000.00 657,000,000.00 1,039,000,000.00 1,421,000,000.00 307,000,000.00 382,000,000.00 382,000,000.00 300,000,000.00 606,000,000.00 944,000,000.00 1,242,000,000.00 306,000,000.00 338,000,000.00
Profit (loss) 1,136,000,000.00 2,266,000,000.00 3,520,000,000.00 4,825,000,000.00 1,130,000,000.00 1,254,000,000.00 1,207,000,000.00 2,187,000,000.00 3,476,000,000.00 4,706,000,000.00 980,000,000.00 1,289,000,000.00 1,289,000,000.00 1,127,000,000.00 2,282,000,000.00 3,554,000,000.00 4,783,000,000.00 1,155,000,000.00 1,272,000,000.00
Line item in (eur) 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023 01.10.2023
Profit (loss) N/A 1,136,000,000.00 1,130,000,000.00 1,254,000,000.00 4,825,000,000.00 1,207,000,000.00 980,000,000.00 1,289,000,000.00 4,706,000,000.00 1,127,000,000.00 1,155,000,000.00 1,272,000,000.00 4,783,000,000.00
Other Adjustments For Noncash Items N/A -48,000,000.00 120,000,000.00 80,000,000.00 -31,000,000.00 -19,000,000.00 172,000,000.00 75,000,000.00 56,000,000.00 -73,000,000.00 -81,000,000.00 -166,000,000.00 -220,000,000.00
Interest Paid Classified As Operating Activities N/A 10,000,000.00 41,000,000.00 67,000,000.00 81,000,000.00 95,000,000.00 55,000,000.00 210,000,000.00 378,000,000.00 102,000,000.00 155,000,000.00 611,000,000.00 809,000,000.00
Interest Received Classified As Operating Activities N/A 14,000,000.00 38,000,000.00 51,000,000.00 31,000,000.00 3,000,000.00 3,000,000.00 8,000,000.00 16,000,000.00 21,000,000.00 12,000,000.00 29,000,000.00 40,000,000.00
Cash Flows From Used In Operating Activities N/A 1,212,000,000.00 1,959,000,000.00 3,336,000,000.00 5,290,000,000.00 1,131,000,000.00 1,381,000,000.00 2,959,000,000.00 5,099,000,000.00 487,000,000.00 1,176,000,000.00 2,345,000,000.00 4,226,000,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A N/A 59,000,000.00 97,000,000.00 97,000,000.00 N/A 10,633,000,000.00 10,633,000,000.00 10,633,000,000.00 N/A 0.00 0.00 7,923,000,000.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 3,000,000.00 4,000,000.00 36,000,000.00 36,000,000.00 0.00 7,000,000.00 10,000,000.00 11,000,000.00 N/A 2,000,000.00 3,000,000.00 8,000,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 975,000,000.00 997,000,000.00 1,022,000,000.00 1,047,000,000.00 26,000,000.00 61,000,000.00 114,000,000.00 208,000,000.00 77,000,000.00 134,000,000.00 161,000,000.00 221,000,000.00
Cash Flows From Used In Investing Activities N/A -1,226,000,000.00 -1,513,000,000.00 -1,710,000,000.00 -2,011,000,000.00 -201,000,000.00 -11,096,000,000.00 -11,358,000,000.00 -11,759,000,000.00 -275,000,000.00 -381,000,000.00 -655,000,000.00 -8,957,000,000.00
Proceeds From Issuing Shares N/A N/A N/A N/A N/A N/A N/A N/A 0.00 N/A N/A N/A 9,100,000,000.00
Payments To Acquire Or Redeem Entitys Shares N/A N/A 61,000,000.00 342,000,000.00 500,000,000.00 N/A 373,000,000.00 500,000,000.00 500,000,000.00 N/A 0.00 0.00 0.00
Proceeds From Borrowings Classified As Financing Activities N/A N/A 0.00 N/A N/A N/A 16,373,000,000.00 N/A N/A N/A N/A N/A N/A
Payments Of Lease Liabilities Classified As Financing Activities N/A 49,000,000.00 99,000,000.00 147,000,000.00 202,000,000.00 49,000,000.00 107,000,000.00 168,000,000.00 239,000,000.00 66,000,000.00 119,000,000.00 180,000,000.00 244,000,000.00
Dividends Paid Classified As Financing Activities N/A 2,765,000,000.00 2,765,000,000.00 3,830,000,000.00 3,830,000,000.00 2,979,000,000.00 2,979,000,000.00 4,041,000,000.00 4,041,000,000.00 3,185,000,000.00 3,185,000,000.00 4,247,000,000.00 4,247,000,000.00
Cash Flows From Used In Financing Activities N/A 125,000,000.00 -369,000,000.00 -1,520,000,000.00 -3,176,000,000.00 -745,000,000.00 9,771,000,000.00 8,550,000,000.00 6,591,000,000.00 74,000,000.00 -549,000,000.00 -1,204,000,000.00 5,265,000,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 111,000,000.00 77,000,000.00 106,000,000.00 103,000,000.00 185,000,000.00 56,000,000.00 151,000,000.00 -69,000,000.00 286,000,000.00 246,000,000.00 486,000,000.00 534,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 1,000,000.00 17,000,000.00 17,000,000.00 20,000,000.00 9,000,000.00 15,000,000.00 37,000,000.00 37,000,000.00 -29,000,000.00 -32,000,000.00 -45,000,000.00 -37,000,000.00
Cash and cash equivalents 323,000,000.00 435,000,000.00 418,000,000.00 447,000,000.00 448,000,000.00 642,000,000.00 517,000,000.00 634,000,000.00 414,000,000.00 671,000,000.00 628,000,000.00 855,000,000.00 911,000,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / DAN /
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
DAN
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DK0060448595

LEI

529900NN7SOJ5QG82X67

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Nasdaq Copenhagen

Stock Index

OMX Copenhagen 20

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.